LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

LLY

818.58

+0.92%↑

JNJ

156.9

+0.22%↑

ABBV

190.58

-0.85%↓

NVO

79.74

-1.64%↓

UNH

313.25

-1.52%↓

Search

Alkermes PLC

Chiusa

SettoreSettore sanitario

29.82 -3.06

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

29.65

Massimo

29.87

Metriche Chiave

By Trading Economics

Entrata

-124M

22M

Vendite

-123M

307M

P/E

Media del settore

15.117

51.748

EPS

0.291

Margine di Profitto

7.329

Dipendenti

1,800

EBITDA

-168M

14M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+33.39% upside

Dividendi

By Dow Jones

Utili prossimi

23 lug 2025

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-596M

5.2B

Apertura precedente

32.88

Chiusura precedente

29.82

Notizie sul Sentiment di mercato

By Acuity

50%

50%

155 / 381 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Alkermes PLC Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

13 giu 2025, 22:33 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefonica Ecuador for $380 Million

14 giu 2025, 01:24 UTC

Acquisizioni, Fusioni, Takeovers

Nippon to Close U.S. Steel Deal After National-Security Pact With Trump -- 3rd Update

13 giu 2025, 23:50 UTC

Acquisizioni, Fusioni, Takeovers

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- 2nd Update

13 giu 2025, 23:20 UTC

Acquisizioni, Fusioni, Takeovers

Trump and Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- Update

13 giu 2025, 23:09 UTC

Acquisizioni, Fusioni, Takeovers

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal -- WSJ

13 giu 2025, 23:03 UTC

Acquisizioni, Fusioni, Takeovers

Trump, Nippon Steel Reach National-Security Agreement on U.S. Steel Deal --WSJ

13 giu 2025, 22:18 UTC

Acquisizioni, Fusioni, Takeovers

Millicom to Acquire Telefonica Ecuador for $380M

13 giu 2025, 22:04 UTC

Discorsi di Mercato
Acquisizioni, Fusioni, Takeovers

Better Data Facilitate Investments In Oil Patch -- Market Talk

13 giu 2025, 21:42 UTC

Acquisizioni, Fusioni, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- 2nd Update

13 giu 2025, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Bunge: Outside Date Extended to July 3

13 giu 2025, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

Bunge: Subject to Satisfaction of Remaining Conditions, Bunge and Sellers Expect to Complete Transaction July 2

13 giu 2025, 21:34 UTC

Acquisizioni, Fusioni, Takeovers

Bunge Gets Mexico Approval for Viterra Deal

13 giu 2025, 21:32 UTC

Acquisizioni, Fusioni, Takeovers

Bunge Gets China Approval for Viterra Deal

13 giu 2025, 20:50 UTC

Discorsi di Mercato

Basic Materials Roundup: Market Talk

13 giu 2025, 20:45 UTC

Acquisizioni, Fusioni, Takeovers

23andMe: TTAM Makes Binding Commitments for Additional Consumer Protections and Privacy Safeguards

13 giu 2025, 20:34 UTC

Acquisizioni, Fusioni, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- Update

13 giu 2025, 20:14 UTC

Acquisizioni, Fusioni, Takeovers

Nonprofit Controlled By 23andMe Co-Founder Anne Wojcicki Would Buy the DNA-Testing Company for $305 Million -- WSJ

13 giu 2025, 20:14 UTC

Acquisizioni, Fusioni, Takeovers

Anne Wojcicki Wins Bidding for 23andMe -- WSJ

13 giu 2025, 20:14 UTC

Acquisizioni, Fusioni, Takeovers

Regeneron Walks Away From 23andMe Acquisition After Wojcicki's Higher Bid -- WSJ

13 giu 2025, 19:30 UTC

Discorsi di Mercato

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

13 giu 2025, 19:12 UTC

Discorsi di Mercato

Oil Futures Jump As Israel Strikes Iranian Targets -- Market Talk

13 giu 2025, 19:04 UTC

Discorsi di Mercato

Canada Military Spending Hike to Lift Long-Term Yields -- Market Talk

13 giu 2025, 18:54 UTC

Discorsi di Mercato

Correction to Gold Settles Market Talk

13 giu 2025, 18:01 UTC

Discorsi di Mercato

Gold Settles at Record High -- Market Talk

13 giu 2025, 17:40 UTC

Discorsi di Mercato

U.S. Oil Rig Count Falls By 3 to 439 -- Market Talk

13 giu 2025, 17:21 UTC

Discorsi di Mercato

Dollar Index, Commodities Rise -- Market Talk

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

Advent Proposal Values Spectris at GBP37.63 Per Share, Company Said Monday -- WSJ

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

KKR Is Preparing a Bid for High-Tech Instrument Maker Spectris, Sources Say -- WSJ

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

Private-Equity Firm Is Vying With Advent for the U.K. Company, Sources Say -- WSJ

13 giu 2025, 17:02 UTC

Acquisizioni, Fusioni, Takeovers

KKR Making Competing Bid for Equipment Maker Spectris -- WSJ

Confronto tra pari

Modifica del prezzo

Alkermes PLC Previsione

Obiettivo di Prezzo

By TipRanks

33.39% in crescita

Previsioni per 12 mesi

Media 39.79 USD  33.39%

Alto 52 USD

Basso 30 USD

Basato su 14 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Alkermes PLC - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

14 ratings

8

Acquista

6

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

27.95 / 30.91Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Strong Bearish Evidence

A lungo termine

Strong Bullish Evidence

Sentiment

By Acuity

155 / 381 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Sotto la media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Alkermes PLC

Alkermes plc is a biopharmaceutical company. The Company is engaged in the researching, developing and commercializing pharmaceutical products that are designed to address medical needs of patients in therapeutic areas. The Company has a portfolio of marketed drug products and a clinical pipeline of products that address central nervous system (CNS) disorders, such as schizophrenia, depression, addiction and multiple sclerosis (MS). The Company's products include ARISTADA, VIVITROL, INVEGA SUSTENNA, XEPLION, INVEGA TRINZA, TREVICTA, RISPERDAL CONSTA, AMPYRA, FAMPYRA, BYDUREON, Aripiprazole lauroxil, ALKS 5461, ALKS 3831, ALKS 8700, ALKS 6428, ALKS 4230 and ALKS 7119. The Company's product platforms include injectable extended-release microsphere technology, LinkeRx technology, NanoCrystal technology and oral controlled release (OCR) technology. ARISTADA is an extended-release intramuscular injectable suspension for the treatment of schizophrenia.